Roche Diagnostics Purchases Microarray Instrument and Accessory Assets from BioMicro Systems
With the purchase of these assets, Roche Diagnostics will transfer the manufacturing capabilities for the above products to an in-house manufacturing facility. According to Andreas Görtz, VP of Marketing at Roche NimbleGen, ‘The acquired products are integral to the high quality data the NimbleGen array workflow provides researchers worldwide. Acquiring these assets will allow Roche complete control over the production, support and service of these products to ensure continued timely distribution, full support and the high level of service our customers have grown to expect from Roche.”
Most read news
Organizations
Other news from the department business & finance
Get the analytics and lab tech industry in your inbox
From now on, don't miss a thing: Our newsletter for analytics and lab technology brings you up to date every Tuesday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.